×
Veradigm Operating Expenses 2010-2022 | MDRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Veradigm operating expenses from 2010 to 2022. Operating expenses can be defined as the sum of all operating expenses for the given industry.
View More
Veradigm Operating Expenses 2010-2022 | MDRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Veradigm operating expenses from 2010 to 2022. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$47.5B
Tempus AI (TEM)
$14B
Doximity (DOCS)
$12.7B
Hims & Hers Health (HIMS)
$10.1B
IRhythm Technologies (IRTC)
$5.4B
Hinge Health (HNGE)
$4.5B
Inspire Medical Systems (INSP)
$2.8B
Privia Health (PRVA)
$2.7B
Heartflow (HTFL)
$2.4B
Enovis (ENOV)
$1.8B
10x Genomics (TXG)
$1.8B
Phreesia (PHR)
$1.8B
Omnicell (OMCL)
$1.5B
Schrodinger (SDGR)
$1.5B
Azenta (AZTA)
$1.4B
Clover Health Investments (CLOV)
$1.4B
Claritev (CTEV)
$1.2B
Evolent Health (EVH)
$1.1B
Fulgent Genetics (FLGT)
$666M
Zepp Health (ZEPP)
$580M
Standard BioTools (LAB)
$485M
Talkspace (TALK)
$469M
Butterfly Network (BFLY)
$383M
Carlsmed (CARL)
$346M
TruBridge (TBRG)
$307M
Outset Medical (OM)
$252M
SOPHiA GENETICS SA (SOPH)
$244M
Health Catalyst (HCAT)
$231M
Nyxoah SA (NYXH)
$219M
KORU Medical Systems (KRMD)
$203M